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Background: Novel methods for cytokine analysis allow for the simultaneous measurement of 25 cytokines in
50 μL serum or plasma. Data on values of most of these cytokines in non-infected newborn infants are lacking. We
analyzed levels of 25 cytokines in the first week of life in non-infected preterm and term infants and related them
to gestational age.
Findings: During the first week after birth, no trend over time was found in any of the cytokines, except for IL-1Ra
and IL-6 where higher values were found in the first four hours. Between 24 and 72 hrs levels of IL-1Ra, IL-2, IL-8,
IL-12, IL-13, IL-15, IL-17, IFNγ, MIP-1a, MCP-1, TNFα were lower in infants born after 30-32 wks compared to infants
≥36 wks; levels of IL-6, IL-10, IP-10 were lower in preterm infants of both 30–32 and 33–36 weeks. No difference
between groups for any of the levels was found for IL-1b, IL-2r, IL-4, IL-5, IL-7, IFNa, MIP-1b, GM-CSF, Eotaxin and
RANTES.
Conclusions: Levels of 25 interleukines are stable in the first week of life in non-infected infants. Infants born after
30-32 wks showed lower levels of fourteen cytokines compared to infants born after more then 36 wks. This
indicates a lower stimulation or activation of Th-1 cells, monocytes and dendritic cells in these infants.
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Infections are an important cause of morbidity and mor-
tality in preterm as well as term infants [1]. Clinical signs
that might indicate the presence of an infection are not
specific. Antibiotics are used frequently when an infection
is suspected. The widespread use of antibiotics has a num-
ber of important side-effects, including the occurrence of
bacterial resistance and the development of an abnormal
gastro-intestinal flora [2]. Reliable methods to detect an
infection in newborn infants therefore are needed. Cyto-
kines and chemokines have been evaluated for this pur-
pose. However, they are still not used in clinical practice.
Studies found higher levels of IL-1Ra, IL-6, IL-8, IP-10
and MIP-1a in infants with a proven infection, but there
was overlap in results between infants with and without
an infection [3-11]. Data on cytokine levels in the first* Correspondence: setyadewi13@yahoo.com
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reproduction in any medium, provided the orweek of life in healthy, non-infected infants are very lim-
ited [12-14]. For some of the cytokines and chemokines
an increase after birth was found, while for others a de-
crease was observed [15,16]. Another unresolved question
is the effect of gestational age on cytokine levels. In most
studies only preterm infants are included.
Studies conducted so far included a limited number of
interleukines. Using the Luminex array it has become
possible to measure up to 25 cytokines and chemokines
at the same time in only 50 μl of plasma or serum. A
number of these 25 cytokines have not been evaluated as
potential markers for neonatal infection. Before a cyto-
kine can be used in daily practice it is essential to know
levels in non infected infants and to know if these level
are related to gestational age. The aim of this study is to
measure sequentially in the first week of life 25 cytokines
and chemokines in non-infected infants with different
gestational ages admitted to our neonatal intensive care
unit.Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Subjects
This study is part of a large prospective study on inter-
leukin levels conducted at the NICU of Harapan-Kita
Women and Children Hospital, Jakarta, Indonesia from
October 2007 till October 2009. For the present study
patients were selected by consecutive sampling when
they were inborn and showed no clinical signs compatible
with an infection during the first seven days of life other
than mild respiratory problems for which N-CPAP was
given with 21% of FiO2. As CPAP is used very frequent in
our unit for mild respiratory problems in infants without
other symptoms, the use of CPAP was allowed. The blood
culture, taken soon after birth, had to be negative. As is
practice in our NICU, all infants admitted with -mild-
respiratory problem, were treated with broad spectrum
antibiotics (Ampicillin-sulbactam and an aminoglycoside).
The study was approved by the Research Ethical Commit-
tee, Harapan Kita Women and Children Hospital, Jakarta.
Informed consent was obtained from the parents when
infants were included.
Routine laboratory and cytokine measurement
Blood was taken on admission for clinical purposes, in-
cluding a blood culture. An additional 0.3 ml was taken
for cytokine levels. Thereafter the same amount of blood
was taken at 4, 12, 24 hrs and at day 2, 3, 4, 5, 6 and 7 to-
gether with blood taking for clinical purposes. In infants
with a gestational age of 32 weeks and less the blood sam-
pling for this study was stopped after day three, as it is
was considered not ethical to take blood in these tiny in-
fants for study purposes only. The blood sample was cen-
trifuged immediately, 50 μl of serum was sampled and
stored at −80°C. Samples were shipped on dry ice to the
University Medical Center Groningen, The Netherlands,
where they were analyzed. Sera were thawed and analysedTable 1 Characteristics between study groups
Characteristics 30 - 32 wee
(n = 11)
GA (wks). Median (25–75th) 32 (31 – 32
BW (gram), mean (range) 1557 (1415 – 1
C-Section 10
Gender: Male 3
AS less than 5 at 5 min 0
Clinical Amnionitis@ 4
CPAP (duration (days)) 10 (3)
Leucocyte < 5000 or > 30.000/mm3 1
Thrombocyte < 150.000 or > 600.000/mm3 1
Day antibiotics (median) 5 (3 – 12
Length of hospitalization at NICU (mean)(days) 16 (8 – 23)
@: PROM more than 12 hours; decceleration CTG; Maternal fever ≥ 38°C; Maternal leusing Invitrogen’s Multiplex Bead Immunoassay. In a 96
well plate samples were prepared by adding beads of de-
fined spectral properties which were conjugated to
protein-specific capture antibodies, incubation buffer to
bind cytokines to the protein-specific capture antibodies
and biotinylated detector antibodies. Finally streptavidin
conjugated to the light-sensitive fluorescent protein R-
Phycoerythrin was added and cytokine concentrations
were analyzed with the Luminex detection system (Lumi-
nex Corp., Austin, Texas) using the programme StarSta-
tion 2.3. By monitoring the spectral properties of the
beads and the amount of associated R-Phycoerythrin
(RPE) fluorescence, the concentration of proteins was de-
termined. The cytokines/chemokines of IL-1b, IL-1Ra, IL-
2, IL-2r, IL-4, IL-5, IL-6, IL-7, IL-8 (CXCL-8), IL-10, IL-12,
IL-13, IL-15, IL-17, TNFα, IFNa, IFNγ, IP-10 (CXCL-10),
MIP-1a (CCL-3), MIP-1b (CCL-4), Eotaxin, Rantes (CCL-5),
GM-CSF, MIG, MCP-1 (CCL-2) were measured.
Statistical analysis
To study the effect of gestational age the infants were di-
vided in three groups, 30-32 wks, 33-35 wks and ≥36 wks.
Differences between groups were analyzed by Non Para-
metric statistic (Mann–Whitney U test). The trend over
time was evaluated using the Rank- Spearman test. To
correct for multiple comparisons, the significance for all
analysis was set at p < 0.01.
Findings
We studied thirty-four non-infected inborn infants admit-
ted at our NICU of Harapan Kita Women and Children
Hospital. Clinical characteristics of these infants are given
in Table 1. None of the infants did have perinatal asphyxia,
as indicated by an Apgar score of at least 5 after 5 minutes.
The majority of infants were born by caesarean section.
One mother showed fever before birth. As is practice inks 33 – 35 weeks ≥ 36 weeks
(n = 14) (n = 9)
) 34(33 – 34) 38 (36.5 – 38.5)





11 (3) 8 (3)
0 2
3 2
4 (4 – 7) 4 (4 – 6)
7 (4 – 10) 8 (6 – 9)
ucocytes > 15.000/mm3.
Table 2 Serum concentrations of 25 cytokines and chemokines (pg/ml) between 3 study groups during first week of life
Cytokinec/chemokines GROUP
After birth hours ≤ 32 wks (n = 11) 33 - 35 wks (n = 14) ≥ 36 wks (n = 9)
1. IL1B:
- 0 0 (0–15) 1 (0–23) 7 (0–17)
- 4 0 (0–4) 1 (0–30) 4 (0–20)
- 24-72 0 (0–1) 1 (0,25-7,75) 4 (0,5-23)
- 96-168 4 (0,75-17) 4 (0–14)
2. IL1RA:
- 0 413 (158–931) 512 (179–22246) 803 (200–2376)
- 4 2026 (63–13795) 596 (119–10464) 4183 (331–14702)
- 24-72 242 (168–354)@& 508,5 (737,3-302,5) 545 (407–698)
- 96-168 395,5 (309,8-556,8) 441 (179–613)
3. IL2:
- 0 3,5 (3–7) 4 (1–15) 14 (3–18)
- 4 3 (3–5)@ 4 (1–17) 14 (4–17)
- 24-72 3.5 (3–6.75)@ 4 (3–10,5) 14 (5–15,5)
- 96-168 9,5 (3–16,5) 14 (13–16)
4. IL2R:
- 0 325 (236–427) 365 (202–604) 295 (145–507)
- 4 300,5 (219–443) 349 (179–621) 295 (212–604)
- 24-72 458 (332–617) 427 (268,5-556) 507 (387,5-631,5)
- 96-168 692 (356,5-846) 610 (572–652)
5. IL4:
- 0 2 (0–5) 5 (2–112) 2 (1–3)
- 4 2 (0–5) 5 (2–128) 5 (1–10)
- 24-72 2 (0–2) 4 (2–94) 3 (1–5,5)
- 96-168 4,5 (2–22) 3 (1–6)
6. IL5:
- 0 2 (0–2) 5 (0–34) 6 (0–8)
- 4 2 (0–3) 5 (0–33) 6 (0–8)
- 24-72 2,5 (2–4) 5 (2–7) 6 (2,3-8)
- 96-168 8,5 (6–9,5) 6 (6–7)
7. IL6:
- 0 15 (0–1440) 30,5 (1–418) 79 (64–232)
- 4 12 (1–251) 26 (1–212) 94 (7–3135)
- 24-72 4 (1,75-11)@ 5,5 (2–16)@ 17 (3–38)
- 96-168 9,5 (5–29) 3 (2–8,8)
8. IL7:
- 0 0 (0–0) 6 (0–40) 0,5 (0–1)
- 4 0 (0–12) 3 (0–32) 0,5 (0–3)
- 24-72 0 (0–0) 0 (0–8) 0 (0–6)
- 96-168 3,5 (0–13,5) 0 (0–5,5)
9. IL8:
- 0 57 (8–204) 98,5 (1–396) 40 (34–46)
- 4 28,5 (10–157) 46 (1–189) 82,5 (13–189)
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Table 2 Serum concentrations of 25 cytokines and chemokines (pg/ml) between 3 study groups during first week of life
(Continued)
- 24-72 19,5 (12,7-39,7)@& 44 (22,75-85,5) 57 (28–170)
- 96-168 44,5 (24–78,25) 37,5 (13–64,3)
10. IL10:
- 0 3 (3–29) 14,5 (0–74) 22 (22–25)
- 4 3,5 (1–28) 9 (1–49) 23 (2–48)
- 24-72 3 (2–3)@ 3 (2–11)@ 21 (3,3-22)
- 96-168 14 (3–21) 21 (3–21,8)
11. IL12:
- 0 418,5 (179–693) 473 (215–815) 278 (202–1837)
- 4 461,5 (144–628) 345 (171–960) 1151 (258–1883)
- 24-72 263 (225–339)@& 384 (199,8-517,8) 402 (295,5-499,3)
- 96-168 358 (243,8-445,8) 431 (219–602)
12. IL13:
- 0 0 (0–7) 7 (0–26) 12 (0–70)
- 4 0 (0–7) 1 (0–22) 14,5 (0–81)
- 24-72 0 (0–7)@ 1,5 (0–8,5) 12 (0–25)
- 96-168 7 (0–17) 17 (12–26)
13. IL15:
- 0 0 (0–0) 13 (0–64) 37 (0–49)
- 4 0 (0–0)@& 10 (0–49) 39 (0–53)
- 24-72 0 (0–0)@& 13 (0–42) 41 (0–53)
- 96-168 39,5 (0–52) 37 (28–47)
14. IL17:
- 0 0 (0–0) 36 (0–130) 23 (0–33)
- 4 0 (0–6)@& 26 (0–146) 22 (6–38)
- 24-72 0 (0–1)@& 27,5 (0,8-44,8) 18 (8,5-31,5)
- 96-168 29 (4,5-41,8) 19 (0–28)
15. TNFA:
- 0 0 (0–0) 1 (0–6) 3 (0–6)
- 4 0 (0–0)@& 1 (0–7) 3 (0–5)
- 24-72 0 (0–0)@& 1 (0–3,8) 3 (0–4,5)
- 96-168 4 (0–6,3) 4 (0–4)
16. IFNA:
- 0 36 (20–49) 40 (18–88) 30 (8–58)
- 4 20 (0–49) 36 (18–98) 49 (20–79)
- 24-72 36 (22,5-49) 49 (26–64,5) 36 (30–44,5)
- 96-168 44,5 (36–75) 40 (30–49)
17. IFNG:
- 0 3 (3–3) 8 (2–449) 7 (3–8)
- 4 3 (2–4) 8 (3–603) 7 (3–9)
- 24-72 3 (3–3,75)@& 7,5 (3–43) 7 (4–8,5)
- 96-168 8 (4–15,5) 7 (7–8)
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Table 2 Serum concentrations of 25 cytokines and chemokines (pg/ml) between 3 study groups during first week of life
(Continued)
18. GM_CSF:
- 0 0 (0–0) 1 (0–48) 0 (0–1)
- 4 0 (0–0) 1 (0–27) 0 (0–34)
- 24-72 0 (0–0) 0 (0–2) 0 (0–10,5)
- 96-168 1 (0–22) 0 (0–7)
19. MIP1A:
- 0 24 (22–32) 28 (23–150) 28 (19–34)
- 4 23 (22–34) 26 (18–150) 30 (23–36)
- 24-72 23,5 (23–25)@& 29,5 (25–36,8) 28 (26–37)
- 96-168 30 (25–38,8) 26 (24–32)
20. MIP1B:
- 0 82 (23–191) 74 (34–345) 40 (22–237)
- 4 74 (51–133) 66 (41–550) 83 (57–250)
- 24-72 41,5 (21–110,75) 80 (54–145,5) 66 (47,3-120,3)
- 96-168 86,5 (45,5-149,3) 60 (42–90)
21. IP10:
- 0 19 (8–144) 32,5 (8–85) 115 (16–124)
- 4 29,5 (3–162) 29 (6–119) 72,5 (19–119)
- 24-72 24,5 (16–54)@ 37 (18,8-56,3) 82,5 (47–136,8)
- 96-168 61 (39–140,3) 55,5 (34–133,75)
22. MIG:
- 0 32 (23–71)@ 41 (8–118) 0 (0–8)
- 4 23 (0–41) 23 (0–145) 8 (0–47)
- 24-72 23 (23–41) 35,5 (23–57) 41 (2–47)
- 96-168 61 (39–140,3) 23 (8–47)
23. EOTAXIN:
- 0 24 (14–37) 35 (10–221) 9 (4–40)
- 4 30,5 (11–80) 33 (10–86) 39 (12–220)
- 24-72 30 (16,5-65) 51 (36,5-81,5) 32,5 (26,3-61,5)
- 96-168 54 (28,5-67,5) 41 (25–55)
24. RANTES:
- 0 1200 (1200–4967) 1200 (1000–18288) 1000 (1000–1200)
- 4 1200 (1200–9900) 1200 (1000–18248) 1000 (1000–1443)
- 24-72 1200 (1200–2821) 1200 (1200–10608,8) 1000 (1000–1200)
- 96-168 1100 (1000–1718,8) 1000 (1000–1132)
25. MCP1:
- 0 439,5 (234–3238) 399 (120–2252) 163 (69–2786)
- 4 355,5 (0–3841) 433 (84–1685) 1119 (210–11314)
- 24-72 275,5 (141–516)@ 463 (319,8-836) 934 (401–3650)
- 96-168 378 (270,8-650,3) 406 (189–879)
Data shown as median (min-max).
Used Mann Whitney U test.
@: p < 0.01; comparison between group ≤32 wks / 33–35 wks and group term.
&: p < 0.01; comparison betweeen group ≤32 wks and group 33–35 wks.
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just before birth, mainly because of the caesarean section.
The blood culture was negative in all infants, except for
one preterm infant who showed a positive blood culture
with Coagulase positive staphylococcus, this was consid-
ered a contamination.
Most of cytokines and chemokines were detected in al-
most all infants. The results of all interleukin levels are
presented in Table 2, in relation to gestational age. There
was no difference in cytokines levels between infants who
received antibiotics for less and more than five days. IL-
1Ra and IL-6 showed higher and more variable values in
the first four hours after birth compared to the period
thereafter, no trend over time was found during the rest of
the first week. No trend over time was found in any of the
other interleukines. Levels of IL-1b, IL-2r, IL-4, IL-5, IL-7,
IFNa, GM-CSF, MIP-1b, Eotaxin and RANTES were not
different at any time point between different gestational
age groups. Levels of IL-2, IL-15, IL-17 and TNFα were
lower in the infants born at 30-32 wks compared to the
group > 36 wks at 4 and 24–72 hours. In the period
24–72 hours, levels of IL-1Ra, IL-6, IL-8, IL-12, IL-13,
IFNγ, MIP-1a, IP-10 and MCP-1 were lower in the
group 30-32 wks compared to ≥36 wks. Levels of IL-6,
IL-10 and IP-10 were lower in the period 24–72 hours
in the group 30–32 wks compared to the older infants.
MIG was lower at birth in infants 30–32 weeks compared
to the other groups.
Discussion
In this paper we show that levels of 25 cytokines/che-
mokines in non-infected newborn infants are constant
between day 2 and 7 in both preterm and term infants.
Levels of IL-1Ra, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13,
IL-15, IL-17, TNFα, IFNγ, MIP-1a, IP-10 and MCP-1
are lower in infants born at 30-32wks compared to infants
born at or ≥36 wks at day two and three days of life. IL-6,
IL-10 and IP-10 were also lower in the group born be-
tween 33 and 35 weeks compared the group ≥36 wks.
Matoba et al. [14] recently described levels of 27 im-
mune biomarkers in cord blood. Concentrations of 12
biomarkers (IL-2, IL-4, IL-5, IL-8, IL-10, MCP-1, MIP-1a,
MIP-1b, sIL-6ra, sTNF-RI, TNFα and TREM-1) were
higher in preterm compared to term infants, while IL-1b
and IL-18 were lower. These authors assumed that the
higher level of a number of cytokines were related to
preterm birth. It is not sure however if preterm birth it-
self caused an increased level in cytokines or that a
common factor like an infection caused both an in-
crease in cytokines level and preterm birth. The inci-
dence of chorioamnionitis for instance was higher in
group preterm compared to term infants. Levels of the
pro-inflammatory cytokines MIP-1a and MIP-1b showed
the highest correlation between gestational age andcytokines levels. Preliminary data from studies con-
ducted by us as well as other studies indicate that
MIP1a and MIP1b are specific markers for a bacterial
infection. The study of Matoba did not provide data on
blood cultures in the infants, also no data on cytokine
levels during the first week of life. A recent study by
McElrath et al. [17] showed that cytokines measured on
the first day of life were higher in preterm infants born
after complications that are associated with infections
compared to preterm infants born after complications
like pre-ecclampsia. Blanco-Quiros [18] observed higher
values of IL-10, but not of IL-12 in preterm compared
to term infants. The higher levels of IL-10 were mainly
found in infants less than 30 weeks, not included in our
study. Moreover, they analysed cord blood while we
took our first sample from the infant itself. Dembinski
et al. [19] did not find an influence of gestational age on
IL-10 levels in cord blood. In that study only IL-6 and
GM-CSF were higher in cord blood in term vs. preterm
infants.
Our study has a number of limitations. The number of
infants included into the study is relatively small. It is
difficult however to take sequential, daily, blood samples
in healthy preterm and term infants. Therefore we
included infants who after birth were on N-CPAP that
needed to take blood samples. Secondly, we did not
include infants of less than 30 weeks. At the start of the
study we realized that the number of these infants
admitted to our unit is too small to be able to include a
sufficient number in this study. Finally, a limitation of
our study is that we included infants who did receive
CPAP and therefore might be not considered as com-
pletely healthy infants. There were no other signs that
made them suspected of having an infection. All infants
included in this study received antibiotics, as it is prac-
tice in our unit to prescribe antibiotics to all infants
showing respiratory problems at birth. Still, all infants
were stable during the whole first week of life, not
showing signs indicating an infection. In all infants a
blood culture was taken on admission and found to be
negative. We are convinced therefore that all included
infants did not have an infection. Our definition of the
non infected group is consistent with the definition
used by Ng et al. [9].
In conclusion, levels of 25 interleukines are stable in
the first week of life in non-infected infants. Infants born
after 30-32 wks showed lower levels of fourteen cytokines
compared to infants born after more then 36 wks. This
indicates a lower stimulation or activation of Th-1 cells,
monocytes and dendritic cells in these infants.Abbreviations
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